SULLIVAN LOUIS W bought UTHR
December 22, 2025 · Form 4 insider transaction
SULLIVAN LOUIS W bought 3,230 shares of United Therapeutics Corporation at $183.98 per share, a transaction worth $594.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,230
Price
$183.98
Total value
$594.3K
InsiderSULLIVAN LOUIS W
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after3,230
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power.